Immediate Impact
2 from Science/Nature 55 standout
Citing Papers
The hallmarks of cancer immune evasion
2024 Standout
Datopotamab Deruxtecan in Advanced or Metastatic HR+/HER2– and Triple-Negative Breast Cancer: Results From the Phase I TROPION-PanTumor01 Study
2024 Standout
Works of Arnd Nusch being referenced
Overall survival (OS) in patients (pts) with advanced breast cancer (ABC) with visceral metastases (mets), including those with liver mets, treated with ribociclib (RIB) plus endocrine therapy (ET) in the MONALEESA (ML) -3 and -7 trials.
2020
Patient-reported outcomes (PROs) in advanced breast cancer (ABC) treated with ribociclib + fulvestrant: Results from MONALEESA-3
2018
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Arnd Nusch | 447 | 421 | 204 | 49 | 694 | |
| Katarzyna Pogoda | 380 | 494 | 167 | 49 | 681 | |
| Marcello Ferretti Fanelli | 298 | 404 | 235 | 46 | 678 | |
| Alain Livartowski | 480 | 442 | 256 | 45 | 844 | |
| Antonio Santo | 345 | 303 | 106 | 54 | 705 | |
| Barbara Radecka | 289 | 435 | 131 | 57 | 618 | |
| Jian Zhang | 225 | 366 | 157 | 57 | 684 | |
| Ruofan Huang | 387 | 412 | 174 | 37 | 707 | |
| Hiroyuki Yasojima | 324 | 497 | 181 | 50 | 662 | |
| Olga Martínez‐Sáez | 326 | 434 | 283 | 60 | 778 | |
| Claudia Andreetta | 200 | 501 | 291 | 41 | 795 |
All Works
Loading papers...